Ajanta Pharma Ltd
NSE: AJANTPHARM BSE: 532331
₹3048.20
(1.61%)
Thu, 19 Mar 2026, 02:29 pm
Market Cap374.81B
PE Ratio37.54
Dividend0.93
Health Technology
Pharmaceuticals: Major
24.5KAjanta Pharma Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.30B | 2.58B | 3.09B | 3.49B | 4.08B | 5.05B | 6.71B | 9.20B | 11.78B | 14.53B | 17.14B | 19.16B | 20.60B | 20.16B | 25.62B | 28.47B | 32.96B | 37.28B | 41.82B | 46.15B |
| Gross profit | 323.44M | 865.87M | 1.31B | 1.67B | 1.91B | 2.56B | 3.17B | 4.46B | 6.36B | 8.37B | 10.12B | 11.55B | 12.14B | 10.11B | 12.00B | 13.81B | 14.84B | 15.37B | 18.72B | 20.70B |
| Operating expenses (excl. COGS) | -74.39M | -555.85M | -872.65M | -1.17B | -1.34B | -1.84B | -2.13B | -2.66B | -3.41B | -4.11B | -4.56B | -5.47B | -6.61B | -5.35B | -5.99B | -5.17B | -7.02B | -8.26B | -8.29B | -9.53B |
| Selling/general/admin expenses, total | — | -548.05M | -862.44M | -1.16B | -1.32B | -1.84B | -2.13B | -2.65B | -3.40B | -4.10B | -4.76B | -5.47B | -6.60B | -5.34B | -5.98B | -5.16B | -7.00B | -8.24B | -8.27B | -9.52B |
| Research & development | -15.94M | -17.51M | -35.90M | -68.69M | -202.65M | -478.79M | -374.03M | -373.10M | -499.30M | -700.70M | -1.06B | -1.50B | -1.86B | -1.76B | -1.94B | -1.39B | -2.04B | -2.37B | -2.08B | -2.24B |
| Selling/general/admin expenses, other | — | -530.55M | -826.54M | -1.09B | -1.12B | -1.36B | -1.76B | -2.28B | -2.90B | -3.40B | -3.69B | -3.96B | -4.74B | -3.58B | -4.05B | -3.77B | -4.96B | -5.87B | -6.20B | -7.27B |
| Other operating expenses, total | -74.39M | -7.79M | -10.21M | -10.02M | -24.07M | 0 | -1.29M | -6.20M | -9.40M | -3.10M | 196.10M | -5.40M | -9.60M | -6.10M | -12.80M | -15.50M | -16.70M | -16.20M | -14.30M | -17.70M |
| Operating income | 249.06M | 310.02M | 435.25M | 500.15M | 565.15M | 718.97M | 1.04B | 1.80B | 2.95B | 4.26B | 5.56B | 6.07B | 5.53B | 4.76B | 6.00B | 8.64B | 7.82B | 7.11B | 10.43B | 11.16B |
| Non-operating income, total | -109.06M | -122.10M | -154.52M | -210.54M | -177.54M | -153.31M | -131.16M | -32.10M | 350.30M | 299.50M | 29.20M | 407.50M | 691.40M | 384.30M | 638.70M | 364.60M | 1.28B | 341.80M | 708.80M | 727.80M |
| Interest expense, net of interest capitalized | -120.49M | -123.77M | -161.44M | -235.51M | -201.60M | -178.21M | -154.30M | -191.30M | -87.30M | -59.20M | -48.90M | -13.60M | -4.10M | -11.60M | -119.10M | -82.70M | -102.00M | -58.40M | -72.10M | -207.30M |
| Interest capitalized | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 11.43M | 1.66M | 15.41M | 24.98M | 24.06M | 24.91M | 23.14M | 159.20M | 437.60M | 443.30M | 23.60M | 485.50M | 665.00M | 342.70M | 960.70M | 399.30M | 1.16B | 611.40M | 872.00M | 1.06B |
| Non-operating interest income | 858.00K | 1.33M | 2.76M | 2.77M | 5.00M | 4.39M | 11.32M | 18.60M | 99.20M | 111.40M | 35.20M | 23.90M | 9.50M | 19.10M | 10.60M | 35.10M | 146.50M | 84.60M | 277.10M | 471.60M |
| Miscellaneous non-operating expense | 10.58M | 329.00K | 12.65M | 22.21M | 19.06M | 20.52M | 11.81M | 140.60M | 338.40M | 331.90M | -11.60M | 461.60M | 655.50M | 323.60M | 950.10M | 364.20M | 1.01B | 526.80M | 594.90M | 588.20M |
| Unusual income/expense | — | — | -8.49M | — | — | — | — | — | — | -84.60M | 54.50M | -64.40M | 30.50M | 53.20M | -202.90M | 48.00M | 223.20M | -211.20M | -91.10M | -124.70M |
| Pretax income | 140.00M | 187.91M | 280.73M | 289.61M | 387.61M | 565.66M | 909.58M | 1.77B | 3.30B | 4.56B | 5.59B | 6.48B | 6.23B | 5.14B | 6.64B | 9.00B | 9.09B | 7.45B | 11.14B | 11.89B |
| Taxes | -14.84M | -40.81M | -60.41M | -35.30M | -47.57M | -58.54M | -136.93M | -646.80M | -959.70M | -1.46B | -1.43B | -1.41B | -1.54B | -1.27B | -1.96B | -2.46B | -1.97B | -1.57B | -2.98B | -2.69B |
| Non-controlling/minority interest | -707.00K | -439.00K | -1.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | -1.00M | -50.00K | -24.00K | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 123.46M | 146.61M | 218.81M | 254.31M | 340.04M | 507.13M | 772.66M | 1.12B | 2.34B | 3.10B | 4.16B | 5.07B | 4.69B | 3.87B | 4.68B | 6.54B | 7.13B | 5.88B | 8.16B | 9.20B |
| Net income | 123.46M | 146.61M | 218.81M | 254.31M | 340.04M | 507.13M | 772.66M | 1.12B | 2.34B | 3.10B | 4.16B | 5.07B | 4.69B | 3.87B | 4.68B | 6.54B | 7.13B | 5.88B | 8.16B | 9.20B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 123.46M | 146.61M | 218.81M | 254.31M | 340.04M | 507.13M | 772.66M | 1.12B | 2.34B | 3.10B | 4.16B | 5.07B | 4.69B | 3.87B | 4.68B | 6.54B | 7.13B | 5.88B | 8.16B | 9.20B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 338.57M | 397.46M | 514.00M | 642.14M | 772.48M | 966.45M | 1.36B | 2.14B | 3.39B | 4.78B | 6.00B | 6.69B | 6.13B | 5.48B | 6.95B | 9.79B | 9.06B | 8.41B | 11.78B | 12.60B |
| EBIT | 249.06M | 310.02M | 435.25M | 500.15M | 565.15M | 718.97M | 1.04B | 1.80B | 2.95B | 4.26B | 5.56B | 6.07B | 5.53B | 4.76B | 6.00B | 8.64B | 7.82B | 7.11B | 10.43B | 11.16B |
| Total operating expenses | -2.05B | -2.27B | -2.66B | -2.99B | -3.51B | -4.33B | -5.67B | -7.40B | -8.83B | -10.27B | -11.58B | -13.09B | -15.06B | -15.41B | -19.62B | -19.83B | -25.15B | -30.17B | -31.39B | -34.99B |
| Prepaid expenses | 9.51M | 34.42M | 30.16M | 44.31M | 2.91M | — | 12.68M | 3.40M | 7.00M | 1.80M | 18.20M | 28.90M | 29.30M | 117.00M | 223.60M | 138.40M | 155.80M | 164.40M | 259.20M | 245.80M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | 42.20M | 28.30M | 47.20M | 43.70M | 152.90M | 206.60M | 523.10M | 100.10M | 393.20M | 737.60M |
| Capital and operating lease obligations | 0 | 0 | 37.62M | 38.25M | 10.45M | 113.83M | 0 | 0 | 10.20M | 9.90M | 10.40M | 10.10M | 10.10M | 0 | 119.70M | 181.70M | 169.30M | 249.50M | 235.20M | 347.20M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | 5.70M | 52.69M | 109.21M | 187.86M | 243.20M | 231.20M | 168.40M | 251.20M | 393.60M | 680.00M | 899.70M | 913.20M | 1.02B | 1.30B | 1.31B | 1.43B | 1.47B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Minority interest | 2.93M | 1.60M | 3.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | -17.36M | -23.28M | -29.18M | -29.07M | -40.74M | -58.24M | -87.30M | -146.10M | -410.70M | -1.34B | -1.29B | -3.00M | -794.90M | -1.16B | -829.00M | -822.10M | -896.90M | -6.42B | -3.49B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -87.30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800